Skip to Content

Levosimendan 2.5 mg / ml concentrate for solution for infusion

Licence status
Authorised: 01/04/2022
Active substances
Levosimendan
Dosage Form
Concentrate for solution for infusion
Licence number
PA2165/015/001
Licence holder
AS Kalceks

Licence information

ATC code
C01CX08 levosimendan
Legal supply status
Product subject to prescription which may not be renewed (A)
Place of sale
Supply through pharmacies only
Conditions of Licence
Levosimendan is for in-hospital use only. It should be administered in a hospital setting where adequate monitoring facilities and expertise with the use of inotropic agents are available.
Marketing availability
Marketed
Advertising conditions
Advertising to healthcare professionals only
Licence issued
01/04/2022